News

NHS staff deliver performance improvements despite record demand

The NHS exceeded its faster diagnosis cancer target for the first time in February amid record demand, according to new figures.  Thanks to the hard work of NHS staff, almost four fifths (78.1%) of people received a definitive cancer diagnosis or all clear within four weeks – with almost 200,000 (199,659) patients getting the answer […]

Read more

100,000 patients receive early access to latest cancer therapies on NHS

Almost one hundred thousand cancer patients have now benefitted from early access to the latest and most innovative treatments, thanks to the NHS Cancer Drugs Fund. The NHS is set to hit a major milestone in April with 100,000 cancer patients benefitting from faster access to more than 100 drugs (in over 250 indications) through the […]

Read more

NHS England responds to ministerial statement regarding high risk screening for some women following chest radiotherapy for Hodgkin lymphoma

The Minister of State for Health and Secondary Care has today made a written statement to Parliament regarding steps being taken by the NHS to ensure everyone eligible for the Very High Risk Breast Screening Programme has been referred to their local screening centre.   Steve Russell, NHS national director for vaccinations and screening, said: “The […]

Read more

NHS rolls out new immunotherapy for hundreds of women with advanced endometrial cancer

The NHS will roll out a new immunotherapy that could offer women with advanced endometrial cancer significant extra time before their disease progresses, compared with standard chemotherapy alone. Trials have shown that adding dostarlimab (Jemperli) to chemotherapy can slow the spread of certain forms of endometrial cancer, giving patients the hope of more time to […]

Read more

NHS fast-tracks new therapy for rare ‘graft vs host’ disease

Cancer patients living with a rare disease which attacks the body’s own organs following a life-saving stem cell transplant are set to benefit from a pioneering new medicine on the NHS. Belumosudil (Rezurock ®) is an innovative treatment for chronic graft versus host disease, which develops in around a third of patients who have undergone […]

Read more

Thousands with cancer-causing condition offered life-saving NHS bowel cancer screening

The NHS is offering routine preventative bowel cancer screening to thousands of people in England with a genetic condition that increases their chance of developing certain cancers. This is a world-first move by the health service to help reduce cases and identify bowel cancers earlier when successful treatment and cure is more likely. As part […]

Read more